感染性坏死性胰腺炎的延期或立即引流(POINTER试验):一项随机对照试验的研究方案
POINTER试验是一项随机对照多中心优效性试验,计划纳入104例成人感染性坏死性胰腺炎患者,随机分为立即(24小时内)导管引流组与现行标准延期导管引流组。主要结局为随机化至6个月随访期间的综合并发症指数(CCI),旨在验证立即引流是否优于延期引流。
要点
- 感染性坏死约占所有急性胰腺炎发作的10%,死亡率为15%–20%。
- 现行标准治疗为升阶梯方案:导管引流,必要时行微创坏死组织清除术。
- 导管引流通常推迟至包裹性坏死阶段(约需4周),此延迟源于开放坏死组织清除术时代。
核心结论
- POINTER试验旨在验证感染性坏死性胰腺炎立即导管引流是否较现行延期至包裹性坏死阶段干预的标准策略减少并发症复合终点。
研究设计与样本
- POINTER为随机对照多中心优效性试验,计划纳入104例成人(疑似)感染性坏死性胰腺炎患者。
- 患者随机分为立即(24小时内)导管引流组或现行标准延期导管引流组;两治疗组中如需坏死组织清除术,均优先推迟至包裹性坏死阶段。
主要发现
- 主要结局为综合并发症指数(CCI),覆盖随机化至6个月随访期间的所有并发症。
- 次要结局包括死亡率、并发症、干预(重复)次数、住院和重症监护室(ICU)住院时间、质量调整生命年(QALYs)以及直接和间接费用。
- 标准随访在随机化后3个月和6个月进行。
局限性
- 试验注册为回顾性注册(2015年8月6日注册于ISRCTN,注册号33682933)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infected necrosis complicates 10% of all acute pancreatitis episodes and is associated with 15-20% mortality. The current standard treatment for infected necrotizing pancreatitis is the step-up approach (catheter drainage, followed, if necessary, by minimally invasive necrosectomy). Catheter drainage is preferably postponed until the stage of walled-off necrosis, which usually takes 4 weeks. This delay stems from the time when open necrosectomy was the standard. It is unclear whether such delay is needed for catheter drainage or whether earlier intervention could actually be beneficial in the current step-up approach. The POINTER trial investigates if immediate catheter drainage in patients with infected necrotizing pancreatitis is superior to the current practice of postponed intervention. METHODS: POINTER is a randomized controlled multicenter superiority trial. All patients with necrotizing pancreatitis are screened for eligibility. In total, 104 adult patients with (suspected) infected necrotizing pancreatitis will be randomized to immediate (within 24 h) catheter drainage or current standard care involving postponed catheter drainage. Necrosectomy, if necessary, is preferably postponed until the stage of walled-off necrosis, in both treatment arms. The primary outcome is the Comprehensive Complication Index (CCI), which covers all complications between randomization and 6-month follow up. Secondary outcomes include mortality, complications, number of (repeat) interventions, hospital and intensive care unit (ICU) lengths of stay, quality-adjusted life years (QALYs) and direct and indirect costs. Standard follow-up is at 3 and 6 months after randomization. DISCUSSION: The POINTER trial investigates if immediate catheter drainage in infected necrotizing pancreatitis reduces the composite endpoint of complications, as compared with the current standard treatment strategy involving delay of intervention until the stage of walled-off necrosis. TRIAL REGISTRATION: ISRCTN, 33682933 . Registered on 6 August 2015. Retrospectively registered.
引用
- van Grinsven J, van Dijk SM, Dijkgraaf MG, et al. Postponed or immediate drainage of infected necrotizing pancreatitis (POINTER trial): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31023380. doi:10.1186/s13063-019-3315-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。